Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Merck & Co (NY:MRK)

98.43 +0.81 (+0.83%)
Streaming Delayed Price Updated: 11:04 AM EST, Dec 11, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 3,239,162
Open 98.44
Bid (Size) 98.41 (200)
Ask (Size) 98.45 (300)
Prev. Close 97.62
Today's Range 97.58 - 98.90
52wk Range 73.31 - 105.84
Shares Outstanding 2,531,374,696
Dividend Yield 3.29%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Dividend Stocks for 2026: Where to Invest as the Market Cools ↗
Via MarketBeat
News headline image
2 Pharmaceutical Stocks to Buy at a Discount ↗
Investors are currently so focused on one type of drug that even good companies are being left on the sidelines. 
Via The Motley Fool
Topics Intellectual Property

Performance

YTD
-0.7%
-0.7%
1 Month
+13.5%
+13.5%
3 Month
+17.1%
+17.1%
6 Month
+22.5%
+22.5%
1 Year
-2.5%
-2.5%

More News

Read More
News headline image
Healthcare Sector Falters: S&P 500's Biggest Loser Amid Broader Market Caution
Via MarketMinute
Topics ETFs Economy Intellectual Property
News headline image
Explore the top gainers and losers within the S&P500 index in today's session. ↗
Via Chartmill
News headline image
Here's 1 Major Catalyst Behind Merck Stock's Recent 3.8% Bump ↗
Via The Motley Fool
News headline image
1 Major Factor Behind the Healthcare Sector's Recent Surge ↗
Via The Motley Fool
News headline image
Should You Buy the 3 Highest-Paying Dividend Stocks in the Dow Jones? ↗
Via The Motley Fool
Topics Economy Stocks
News headline image
Merck's Stock is Suddenly Soaring, but Is the Struggling Healthcare Giant a Buy? ↗
Via The Motley Fool
Topics Intellectual Property
News headline image
Do These 3 Healthcare Stocks Need a Checkup? ↗
Via The Motley Fool
Topics Intellectual Property
News headline image
Trading Near Its 52-Week Low, Is Summit Therapeutics a Good Stock to Buy Right Now? ↗
Via The Motley Fool
News headline image
Is This Pharmaceutical Giant a Buy After a Major Acquisition? ↗
Via The Motley Fool
Topics Death
News headline image
These Are the 3 Hottest Stocks in the S&P 500 Heading Into the New Year. Should You Invest in Them? ↗
Via The Motley Fool
Topics Stocks
News headline image
With Netflix's 10-for-1 Stock Split Complete, Here Are 3 Growth Stocks to Buy in December That Could Issue Stock Splits in 2026 ↗
Via The Motley Fool
Topics Artificial Intelligence Economy Stocks
News headline image
FDA Conditionally Approves Merck Animal Health's EXZOLT™ CATTLE-CA1 for the Prevention and Treatment of New World Screwworm (Cochliomyia hominivorax) Larvae (myiasis)
From Merck & Co., Inc.
Via Business Wire
News headline image
3 Top ETFs I Plan to Pile Into in December to Boost My Passive Income in 2026 ↗
Via The Motley Fool
Topics ETFs Stocks
News headline image
Global Prescription Drug Market Poised for Trillion-Dollar Surge by 2035
Via MarketMinute
Topics Artificial Intelligence Death Intellectual Property
News headline image
Wall Street's Tentative Triumph: Dow, S&P 500, Nasdaq Edge Higher Amidst Shifting Tides
Via MarketMinute
Topics Artificial Intelligence Bonds Economy
Chronic Rare Diseases in an Aging America: Why HyBryte and Federal Policy Matter Now
Via Investor Brand Network
Topics Government
News headline image
Chronic Rare Diseases in an Aging America: Why HyBryte and Federal Policy Matter Now
From BioMedWire
Via GlobeNewswire
News headline image
2 Monster Stocks in the Making to Buy and Hold ↗
Via The Motley Fool
News headline image
1 Value Stock to Target This Week and 2 We Question
Via StockStory
News headline image
Global Markets Brace as Treasury Yields Surge Amidst BOJ Speculation and Risk Aversion
Via MarketMinute
Topics Bonds Economy Stocks
News headline image
Treasury Yields Surge Amid Global Shifts and Fiscal Concerns: A Deep Dive into Market Implications
Via MarketMinute
Topics Bonds Credit Cards Economy
News headline image
Merck Showcases Data for Alzheimer's Disease Candidates MK-2214 and MK-1167 at CTAD 2025
From Merck Sharp & Dohme
Via Business Wire
News headline image
These Underrated Companies Could Be "Training-Wheels" Stocks for Long-Term Wealth Builders ↗
Via The Motley Fool
Topics Energy Intellectual Property

Frequently Asked Questions

Is Merck & Co publicly traded?
Yes, Merck & Co is publicly traded.
What exchange does Merck & Co trade on?
Merck & Co trades on the New York Stock Exchange
What is the ticker symbol for Merck & Co?
The ticker symbol for Merck & Co is MRK on the New York Stock Exchange
What is the current price of Merck & Co?
The current price of Merck & Co is 98.43
When was Merck & Co last traded?
The last trade of Merck & Co was at 12/11/25 11:04 AM ET
What is the market capitalization of Merck & Co?
The market capitalization of Merck & Co is 249.16B
How many shares of Merck & Co are outstanding?
Merck & Co has 249B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.